Every 10-Q that Tilray Brands, Inc. (TLRY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow TLRY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TLRY filings page.
Tilray Brands, Inc. (TLRY) reported net revenue of $257.1 million for the three months ended August 31, 2026, compared with $209.5 million a year earlier.
Gross profit was $77.5 million, versus $57.5 million. Beverage net revenue was $101.5 million, compared with $55.7 million, while cannabis net revenue was $56.1 million, compared with $64.5 million. Tilray recorded an operating loss of $24.1 million and a consolidated net loss of $40.0 million, versus operating income of $2.1 million and net income of $1.5 million a year earlier. Operating activities used $16.5 million in cash, compared with $1.3 million.
In September 2026, Tilray issued 2,841,650 common shares in exchange for $12.0 million of principal on its TLRY 27 Notes; $52.0 million of principal remained outstanding as of October 8, 2026. Tilray also sold its 90% interest in Colcanna for nominal cash consideration, with the purchaser assuming the subsidiary’s liabilities. A credit-agreement amendment provides that financial covenants will not be tested for the quarter ended August 31, 2026, revises covenants for later periods, and limits future borrowing availability until covenant testing resumes.
Tilray Brands, Inc. reported higher sales and sharply reduced losses for the quarter ended February 28, 2026. Net revenue rose to $206.7M from $185.8M, led by cannabis, distribution and wellness, while beverage revenue declined year over year.
Gross profit was $55.0M, up slightly from $52.0M. The company posted an operating loss of $26.4M and a net loss of $25.2M, a dramatic improvement from the prior year’s impairment‑driven losses. For the first nine months, net revenue reached $633.7M and net loss narrowed to $67.2M, with basic and diluted loss per share improving to $0.65. Tilray ended the period with $204.6M in cash and equivalents plus $44.9M of restricted cash, while total liabilities were $549.1M and stockholders’ equity was $1.53B.
Tilray Brands, Inc. reported higher sales but continued losses for the quarter ended November 30, 2025. Net revenue reached $217.5 million, up from $211.0 million a year earlier, driven by modest growth in cannabis, distribution, and wellness, partially offset by lower beverage sales. For the first six months of the fiscal year, net revenue was $427.0 million compared with $411.0 million in the prior-year period.
The company posted a quarterly net loss of $43.5 million, an improvement from a $85.3 million loss a year ago, with net loss per share narrowing to $(0.41) from $(0.99). Operating loss also improved as restructuring and amortization expenses declined. Tilray ended the quarter with $246.7 million in cash and cash equivalents and $44.8 million in marketable securities, while carrying $155.6 million of long-term debt (net of fees) and $86.3 million in convertible debentures.
During the period, Tilray completed a one-for-ten reverse stock split, and all share and per-share figures have been retrospectively adjusted. Shares outstanding were 116.5 million as of January 6, 2026. The company also exercised and retired all remaining warrants and modestly reduced the principal outstanding on its TLRY 27 convertible notes.
Tilray Brands, Inc. reported interim financial information prepared under U.S. GAAP for the quarter ended August 31, 2025. The company has 1,416,000,000 common shares authorized and reported 1,118,291,159 shares issued and outstanding with 3,213,914 shares held as treasury stock. Management adopted ASU 2023-08 and purchased 9.16 units of Bitcoin, recording digital assets at fair value (Level 1). The company issued TLRY 27 convertible debentures totaling $172,500 carrying interest at 5.20% and maturing on June 15, 2027, convertible at an initial rate of 376.6478 shares per $1,000 principal (approximate conversion price $2.66 per share). During the period 6,209,000 warrants were exercised for $2,108 cash, and subsequent exchanges reduced outstanding borrowed shares. The company recorded a $15,000 change related to contingent consideration and noted long-term debt and convertible debenture principals of $2,437 and $100,000, respectively. Litigation accruals and restructuring charges were disclosed but not expected by management to be material to consolidated results, while management cautioned that ultimate outcomes could be material.